Workflow, Customers, and Course Corrections: Scott O’Brien on Scaling GenMark

This week on Diagnosing Dx, I’m joined by Scott O’Brien, who helped lead GenMark from a small startup to a $1.8 billion acquisition by Roche.

Scott shares how his transition from science to commercial strategy shaped GenMark’s journey, the critical role of customer experience in competing against industry giants, and what it really takes to scale a diagnostics company through both breakthroughs and setbacks.

🔥 What You’ll Learn:

• How commercial strategy can define success in diagnostics

• The power of customer experience and retention in building long-term value

• Lessons from scaling a startup to a billion-dollar acquisition

• Why adaptability and feedback culture are key to growth

Whether you’re a founder, commercial leader, or diagnostics enthusiast, this conversation offers a rare inside look at the decisions that built one of the sector’s standout success stories.

🔔 Subscribe to Diagnosing Dx for weekly conversations with leaders shaping the future of diagnostics.